Developing an interprofessional team to support patients prescribed long-term high-dose opioid therapy.
Michael P ConleyAbigail T ElmesJohn R RobertsLauren BuckThomas P FantesPublished in: Journal of interprofessional care (2022)
Despite decreases in US opioid prescribing rates, daily morphine milligram equivalents (MME) prescribed per person remains three times higher than in 1999. An interprofessional team (IPT) was developed to support pain management for patients prescribed long-term high-dose opioids (HDO) in a Federally Qualified Health Center. The IPT utilized a clinical pharmacist, addiction nurse, medical director, and another physician or nurse practitioner to manage adults prescribed long-term HDO, defined as exceeding 50 daily MME. Visits focused on patient education including risks associated with long-term HDO use and effective pain management. The IPT engaged in supportive, individualized care planning for safer, evidence-based pain management, which included, but was not limited to opioid tapers, adjuvant non-opioid pain medications (NOPM), non-pharmacological therapy (NPT), and naloxone co-prescribing. The IPT saw 90% (n = 19) of eligible patients. Excluding outliers, the cohort demonstrated an average 18% ± 24.9 decrease in daily MME. The most common NOPM were acetaminophen, NSAIDs, and pregabalin, and the most common NPT were physical, aquatic, and behavioral therapy. Shared decision-making, collaborative teamwork, and simple patient-centered goals are key to moving patients toward safer, evidence-based therapy.
Keyphrases
- pain management
- chronic pain
- end stage renal disease
- high dose
- chronic kidney disease
- ejection fraction
- healthcare
- primary care
- newly diagnosed
- physical activity
- early stage
- prognostic factors
- mental health
- mesenchymal stem cells
- public health
- palliative care
- patient reported outcomes
- case report
- patient safety
- cell therapy
- adverse drug